Per the ASX announcement, the company will be presenting these initial srGVHD results at the forthcoming ISCT annual meeting:
Mesoblast has itself presented both COVID and heart results itself at former ISCT annual meetings and conferences.
Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-57
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $49.39M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.5¢ | $6.183K | 22.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 32514 | 3 |
View Market Depth
| Last trade - 11.18am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
0.005 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 28.0¢ | 27.0¢ | 21201 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| CYP (ASX) Chart |